These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Wright JB; Brown SJ; Cole MD Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031 [TBL] [Abstract][Full Text] [Related]
3. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells. Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031 [TBL] [Abstract][Full Text] [Related]
4. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Meyer MB; Goetsch PD; Pike JW Mol Endocrinol; 2012 Jan; 26(1):37-51. PubMed ID: 22108803 [TBL] [Abstract][Full Text] [Related]
5. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Pomerantz MM; Ahmadiyeh N; Jia L; Herman P; Verzi MP; Doddapaneni H; Beckwith CA; Chan JA; Hills A; Davis M; Yao K; Kehoe SM; Lenz HJ; Haiman CA; Yan C; Henderson BE; Frenkel B; Barretina J; Bass A; Tabernero J; Baselga J; Regan MM; Manak JR; Shivdasani R; Coetzee GA; Freedman ML Nat Genet; 2009 Aug; 41(8):882-4. PubMed ID: 19561607 [TBL] [Abstract][Full Text] [Related]
6. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Tuupanen S; Turunen M; Lehtonen R; Hallikas O; Vanharanta S; Kivioja T; Björklund M; Wei G; Yan J; Niittymäki I; Mecklin JP; Järvinen H; Ristimäki A; Di-Bernardo M; East P; Carvajal-Carmona L; Houlston RS; Tomlinson I; Palin K; Ukkonen E; Karhu A; Taipale J; Aaltonen LA Nat Genet; 2009 Aug; 41(8):885-90. PubMed ID: 19561604 [TBL] [Abstract][Full Text] [Related]
7. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Kim T; Cui R; Jeon YJ; Lee JH; Lee JH; Sim H; Park JK; Fadda P; Tili E; Nakanishi H; Huh MI; Kim SH; Cho JH; Sung BH; Peng Y; Lee TJ; Luo Z; Sun HL; Wei H; Alder H; Oh JS; Shim KS; Ko SB; Croce CM Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4173-8. PubMed ID: 24594601 [TBL] [Abstract][Full Text] [Related]
8. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Desbarats L; Gaubatz S; Eilers M Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028 [TBL] [Abstract][Full Text] [Related]
9. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression. Yochum GS; Cleland R; Goodman RH Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287 [TBL] [Abstract][Full Text] [Related]
10. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Wasserman NF; Aneas I; Nobrega MA Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891 [TBL] [Abstract][Full Text] [Related]
11. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Ahmadiyeh N; Pomerantz MM; Grisanzio C; Herman P; Jia L; Almendro V; He HH; Brown M; Liu XS; Davis M; Caswell JL; Beckwith CA; Hills A; Macconaill L; Coetzee GA; Regan MM; Freedman ML Proc Natl Acad Sci U S A; 2010 May; 107(21):9742-6. PubMed ID: 20453196 [TBL] [Abstract][Full Text] [Related]
12. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression. Si J; Yu X; Zhang Y; DeWille JW Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839 [TBL] [Abstract][Full Text] [Related]
13. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891 [TBL] [Abstract][Full Text] [Related]
14. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression. Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription. Antony L; van der Schoor F; Dalrymple SL; Isaacs JT Prostate; 2014 Aug; 74(11):1118-31. PubMed ID: 24913829 [TBL] [Abstract][Full Text] [Related]
16. A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancers. Yochum GS; Sherrick CM; Macpartlin M; Goodman RH Proc Natl Acad Sci U S A; 2010 Jan; 107(1):145-50. PubMed ID: 19966299 [TBL] [Abstract][Full Text] [Related]
17. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Hann SR; Dixit M; Sears RC; Sealy L Genes Dev; 1994 Oct; 8(20):2441-52. PubMed ID: 7958908 [TBL] [Abstract][Full Text] [Related]
18. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene? Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267 [TBL] [Abstract][Full Text] [Related]
19. Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy. Amjadi-Moheb F; Paniri A; Akhavan-Niaki H Cancer Res; 2021 Apr; 81(8):1925-1936. PubMed ID: 33472888 [No Abstract] [Full Text] [Related]
20. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue. Prokunina-Olsson L; Hall JL Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]